… Aspergillus agent and also the most commonly used antifungal agent, aspergillosis caused
by azole-resistant Aspergillus … of pulmonary aspergillosis in severe/critical COVID-19 patients…

… -infections caused by bacteria and also Aspergillus spp. [7,8]… COVID-19 [10]. In this
comprehensive review, we discuss various aspects of COVID-19 associated pulmonary aspergillosis …

… pulmonary aspergillosis (IPA). A new term has been coined for this condition: COVID-19-associated
pulmonary aspergillosis (CAPA). COVID-19-associated pulmonary aspergillosis has …

… influenza, are prone to invasive aspergillosis even in absence of prior immunodeficiency.
We report putative IPA in five of 19 COVID-19 patients with moderate to severe ARDS without …

… 186 patients who had coronavirus disease–associated pulmonary aspergillosis (CAPA) …
CAPA was diagnosed a median of 10 days after coronavirus disease diagnosis. Aspergillus …

… pulmonary aspergillosis in patients with COVID-19 … COVID-19 and invasive pulmonary
aspergillosis were recently described in France (33% of 27 admitted to the ICU with COVID-19…

… pulmonary aspergillosis (IPA) is increasingly reported in patients with severe coronavirus
disease 2019 (COVID-19… management of COVID-19 associated pulmonary aspergillosis (CAPA…

… Since the first evidence of secondary aspergillosis reported in China, several studies
have … with severe COVID-19, termed COVID-19-associated pulmonary aspergillosis (CAPA). …

… Aspergillus and SARS-CoV-2-infected lungs [35]. Patients with confirmed severe COVID-19
infection and pulmonary … investigation for the presence of Aspergillus infection by the culture …

… COVID-19-associated pulmonary aspergillosis (CAPA) is defined as invasive pulmonary
aspergillosis occurring in COVID-19 … In 1421 COVID-19 patients, the overall CAPA incidence …